Premium
Utility of a clinical risk score to identify high‐risk patients with de novo acute myeloid leukaemia in first remission after high‐dose cytarabine (Hi DAC ) based induction chemotherapy
Author(s) -
Ling Victoria,
Burnett Alan K.,
Bradstock Ken,
Seymour John F.,
Hills Robert K.,
Wei Andrew
Publication year - 2013
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/bjh.12178
Subject(s) - cytarabine , medicine , induction chemotherapy , regimen , oncology , chemotherapy , chemotherapy regimen , cohort , gastroenterology